Featured

Disease Management: Advancements in Identification and Diagnosis of Kidney Diseases



Published
Moderator: Erin Kahle, MPA, CNP, AAKP Director of Patient Insights, Data Analytics, & Advocacy

Speakers:
- Barry I. Freedman, MD, FACP, Chief of Nephrology, Wake Forest School of Medicine
- Jonathan Himmelfarb, MD, (2021 KidneyX Artificial Kidney Prize Winner); Co-Director of the University of Washington Center for Dialysis Innovation, Director of the Kidney Research Institute, Professor of Medicine and Adjunct Professor of Bioengineering
- David Davenport, Personalized Medicine Coalition (PMC), Manager, Public Policy and Secretary to the Board

Session sponsored by Novartis

As the oldest and largest, independent kidney patient organization in the U.S. – AAKP is dedicated to improving the lives and long-term outcomes of kidney patients through education, advocacy, patient engagement and the fostering of patient communities. AAKP fights for early disease detection and the appropriate diagnosis of rare/genetic conditions; increased kidney transplantation and pre-emptive transplantation; full patient choice of either in-center or home dialysis; protection of the patient/physician relationship; promotion of research and innovation including artificial implantable and wearable kidneys; and the elimination of barriers for patient access to available treatment options. Learn more at www.aakp.org.
Category
Health
Be the first to comment